Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 13 | 2023 | 800 | 1.340 |
Why?
|
| Cognitive Dysfunction | 13 | 2023 | 449 | 1.330 |
Why?
|
| Brain | 13 | 2023 | 707 | 1.270 |
Why?
|
| Dementia | 6 | 2021 | 236 | 1.150 |
Why?
|
| Cognition Disorders | 8 | 2020 | 437 | 0.980 |
Why?
|
| Aging | 13 | 2023 | 680 | 0.930 |
Why?
|
| Aged | 40 | 2023 | 4000 | 0.860 |
Why?
|
| Models, Statistical | 2 | 2016 | 60 | 0.840 |
Why?
|
| Humans | 61 | 2023 | 12240 | 0.830 |
Why?
|
| Software | 1 | 2023 | 26 | 0.800 |
Why?
|
| Algorithms | 2 | 2023 | 169 | 0.770 |
Why?
|
| Longitudinal Studies | 13 | 2023 | 651 | 0.760 |
Why?
|
| Cognition | 11 | 2023 | 641 | 0.710 |
Why?
|
| Aged, 80 and over | 28 | 2023 | 2152 | 0.700 |
Why?
|
| Female | 47 | 2023 | 6974 | 0.690 |
Why?
|
| Male | 46 | 2023 | 6815 | 0.690 |
Why?
|
| Educational Status | 2 | 2021 | 130 | 0.670 |
Why?
|
| Death | 1 | 2021 | 24 | 0.660 |
Why?
|
| Music | 1 | 2021 | 11 | 0.650 |
Why?
|
| Literacy | 1 | 2021 | 13 | 0.650 |
Why?
|
| Depression | 5 | 2020 | 229 | 0.580 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 20 | 0.580 |
Why?
|
| Depressive Disorder | 1 | 2019 | 90 | 0.550 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 40 | 0.490 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.480 |
Why?
|
| Risk Factors | 17 | 2021 | 1049 | 0.450 |
Why?
|
| Orthomyxoviridae Infections | 6 | 2012 | 8 | 0.430 |
Why?
|
| Odds Ratio | 3 | 2018 | 115 | 0.420 |
Why?
|
| Intracranial Aneurysm | 4 | 2018 | 19 | 0.400 |
Why?
|
| Influenza, Human | 7 | 2013 | 17 | 0.390 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 40 | 0.380 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 57 | 0.370 |
Why?
|
| Memory, Episodic | 3 | 2023 | 43 | 0.370 |
Why?
|
| Swine Diseases | 5 | 2012 | 5 | 0.350 |
Why?
|
| Influenza A virus | 4 | 2012 | 10 | 0.320 |
Why?
|
| Family | 2 | 2021 | 52 | 0.320 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 151 | 0.310 |
Why?
|
| Body Mass Index | 3 | 2023 | 221 | 0.300 |
Why?
|
| Blood Pressure | 2 | 2019 | 99 | 0.270 |
Why?
|
| HIV Infections | 2 | 2021 | 256 | 0.270 |
Why?
|
| Disease Outbreaks | 3 | 2013 | 38 | 0.250 |
Why?
|
| Hippocampus | 3 | 2019 | 97 | 0.250 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 19 | 0.250 |
Why?
|
| Brazil | 3 | 2021 | 17 | 0.250 |
Why?
|
| Cognitive Aging | 2 | 2018 | 34 | 0.250 |
Why?
|
| Antibodies, Viral | 7 | 2013 | 31 | 0.250 |
Why?
|
| Hospitalization | 2 | 2019 | 158 | 0.250 |
Why?
|
| Zoonoses | 6 | 2008 | 7 | 0.240 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 60 | 0.240 |
Why?
|
| Neuropsychological Tests | 8 | 2023 | 558 | 0.230 |
Why?
|
| Arteriolosclerosis | 2 | 2023 | 25 | 0.230 |
Why?
|
| Independent Living | 3 | 2021 | 137 | 0.220 |
Why?
|
| Brain Infarction | 2 | 2016 | 36 | 0.220 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2021 | 29 | 0.220 |
Why?
|
| Perception | 3 | 2021 | 42 | 0.220 |
Why?
|
| Autopsy | 6 | 2023 | 174 | 0.220 |
Why?
|
| Middle Aged | 16 | 2021 | 4043 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2016 | 90 | 0.210 |
Why?
|
| Interviews as Topic | 2 | 2021 | 66 | 0.200 |
Why?
|
| Stress, Psychological | 2 | 2021 | 112 | 0.200 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2008 | 9 | 0.200 |
Why?
|
| Cohort Studies | 8 | 2019 | 827 | 0.200 |
Why?
|
| Metformin | 1 | 2023 | 9 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 20 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 98 | 0.190 |
Why?
|
| Prospective Studies | 8 | 2023 | 817 | 0.190 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 9 | 0.190 |
Why?
|
| Animals | 11 | 2013 | 2092 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 60 | 0.180 |
Why?
|
| Swine | 6 | 2012 | 43 | 0.180 |
Why?
|
| Lewy Bodies | 3 | 2019 | 96 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2021 | 1467 | 0.180 |
Why?
|
| Cause of Death | 1 | 2021 | 32 | 0.170 |
Why?
|
| Ventriculostomy | 2 | 2012 | 3 | 0.170 |
Why?
|
| Exercise | 2 | 2021 | 233 | 0.170 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.170 |
Why?
|
| Writing | 1 | 2021 | 10 | 0.170 |
Why?
|
| Social Discrimination | 1 | 2021 | 5 | 0.170 |
Why?
|
| Reading | 1 | 2021 | 12 | 0.170 |
Why?
|
| Occupational Exposure | 6 | 2013 | 9 | 0.160 |
Why?
|
| Neuropathology | 2 | 2019 | 42 | 0.160 |
Why?
|
| Physical Fitness | 1 | 2020 | 23 | 0.160 |
Why?
|
| Influenza in Birds | 3 | 2011 | 3 | 0.150 |
Why?
|
| Adenoviruses, Human | 2 | 2009 | 2 | 0.150 |
Why?
|
| Adipokines | 1 | 2019 | 5 | 0.150 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 64 | 0.150 |
Why?
|
| Memory Disorders | 1 | 2020 | 68 | 0.150 |
Why?
|
| Insulin | 1 | 2019 | 41 | 0.150 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 8 | 0.150 |
Why?
|
| Motor Disorders | 1 | 2019 | 13 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.150 |
Why?
|
| Cerebral Arteries | 2 | 2016 | 18 | 0.150 |
Why?
|
| Disease Progression | 2 | 2019 | 290 | 0.140 |
Why?
|
| Adult | 13 | 2018 | 3557 | 0.140 |
Why?
|
| Adenovirus Infections, Human | 2 | 2009 | 2 | 0.140 |
Why?
|
| Logistic Models | 2 | 2016 | 196 | 0.140 |
Why?
|
| Proteomics | 1 | 2019 | 39 | 0.140 |
Why?
|
| Emergencies | 1 | 2019 | 26 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2019 | 66 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 26 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 3 | 2018 | 12 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 53 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 66 | 0.140 |
Why?
|
| Age Factors | 5 | 2021 | 350 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2019 | 246 | 0.140 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 48 | 0.140 |
Why?
|
| Rural Population | 3 | 2013 | 8 | 0.130 |
Why?
|
| Learning | 1 | 2018 | 34 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 60 | 0.130 |
Why?
|
| Hypertension | 1 | 2018 | 85 | 0.130 |
Why?
|
| Antibodies, Bacterial | 2 | 2008 | 2 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 726 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 73 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2017 | 36 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 186 | 0.120 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2007 | 2 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2016 | 12 | 0.120 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 2 | 2013 | 2 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2016 | 22 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 115 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 55 | 0.110 |
Why?
|
| Infant | 5 | 2023 | 277 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2015 | 20 | 0.110 |
Why?
|
| United States | 7 | 2019 | 989 | 0.110 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 6 | 0.100 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 6 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 20 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2014 | 44 | 0.100 |
Why?
|
| Young Adult | 6 | 2013 | 863 | 0.100 |
Why?
|
| Sclerosis | 3 | 2019 | 32 | 0.090 |
Why?
|
| Third Ventricle | 1 | 2012 | 1 | 0.090 |
Why?
|
| Chicago | 3 | 2020 | 453 | 0.090 |
Why?
|
| Asymptomatic Infections | 1 | 2011 | 1 | 0.090 |
Why?
|
| Poultry Diseases | 1 | 2011 | 2 | 0.090 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 2008 | 2 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 464 | 0.090 |
Why?
|
| Child, Preschool | 5 | 2012 | 320 | 0.080 |
Why?
|
| Aspirin | 1 | 2011 | 20 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 57 | 0.080 |
Why?
|
| Iowa | 5 | 2008 | 8 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 9 | 0.080 |
Why?
|
| Stents | 1 | 2010 | 28 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 400 | 0.080 |
Why?
|
| Self Report | 2 | 2021 | 94 | 0.080 |
Why?
|
| Seroepidemiologic Studies | 5 | 2008 | 9 | 0.080 |
Why?
|
| Child | 5 | 2012 | 614 | 0.080 |
Why?
|
| Agriculture | 2 | 2008 | 2 | 0.080 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 36 | 0.080 |
Why?
|
| Adenoviridae Infections | 1 | 2009 | 2 | 0.080 |
Why?
|
| Streptococcus suis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 5 | 0.070 |
Why?
|
| Animal Husbandry | 1 | 2008 | 4 | 0.070 |
Why?
|
| Adolescent | 5 | 2012 | 989 | 0.070 |
Why?
|
| Neutralization Tests | 1 | 2008 | 3 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 12 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 141 | 0.070 |
Why?
|
| Veterinarians | 1 | 2007 | 1 | 0.060 |
Why?
|
| Influenza A Virus, H5N2 Subtype | 1 | 2007 | 1 | 0.060 |
Why?
|
| Paramyxoviridae Infections | 1 | 2006 | 1 | 0.060 |
Why?
|
| Metapneumovirus | 1 | 2006 | 1 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 12 | 0.060 |
Why?
|
| Deer | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ehrlichiosis | 1 | 2006 | 1 | 0.060 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2006 | 1 | 0.060 |
Why?
|
| Poultry | 3 | 2011 | 3 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 132 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 256 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 209 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2023 | 63 | 0.050 |
Why?
|
| 5-Methylcytosine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 37 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 72 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2023 | 93 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 22 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 229 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 47 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 83 | 0.040 |
Why?
|
| Leptin | 1 | 2019 | 11 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2019 | 17 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 59 | 0.030 |
Why?
|
| Birds | 2 | 2008 | 4 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 1478 | 0.030 |
Why?
|
| Social Isolation | 1 | 2018 | 15 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 261 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 294 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 51 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 25 | 0.030 |
Why?
|
| Arterioles | 1 | 2016 | 9 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 18 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 26 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 7 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 77 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 53 | 0.030 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2014 | 6 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2014 | 6 | 0.030 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
|
| Autoantigens | 1 | 2014 | 10 | 0.030 |
Why?
|
| Memory | 1 | 2015 | 112 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 46 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 38 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 24 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 36 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 27 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2014 | 59 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 166 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 258 | 0.020 |
Why?
|
| Cambodia | 1 | 2013 | 8 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 2012 | 2 | 0.020 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 4 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2012 | 9 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 34 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 99 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 125 | 0.020 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 1 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 85 | 0.020 |
Why?
|
| Thailand | 1 | 2011 | 5 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 58 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 218 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 6 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 19 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 97 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2010 | 21 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 338 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 28 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 546 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2009 | 8 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2009 | 2 | 0.020 |
Why?
|
| Connecticut | 1 | 2009 | 6 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 4 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 16 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2009 | 25 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 281 | 0.020 |
Why?
|
| Serotyping | 1 | 2008 | 6 | 0.020 |
Why?
|
| Horses | 1 | 2008 | 2 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2008 | 19 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 312 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 13 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 4 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 40 | 0.020 |
Why?
|
| Peru | 1 | 2007 | 1 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 324 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 19 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 169 | 0.020 |
Why?
|
| Prevalence | 1 | 2007 | 175 | 0.020 |
Why?
|
| Phylogeny | 1 | 2006 | 35 | 0.020 |
Why?
|
| Hemagglutination Tests | 1 | 2006 | 1 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 36 | 0.020 |
Why?
|
| Hospitals | 1 | 2006 | 68 | 0.010 |
Why?
|
| Arachnid Vectors | 1 | 2006 | 1 | 0.010 |
Why?
|
| Ixodes | 1 | 2006 | 1 | 0.010 |
Why?
|
| Animals, Wild | 1 | 2006 | 2 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 4 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 2006 | 8 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 62 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 191 | 0.010 |
Why?
|